Dr. Arndt Brachat is a pharma-professional with over 17 years of experience in cancer target discovery and biomarker development in various indications as well as in personalized medicine.

Topics of relevance for his previous work include analyzing biomarker data for class comparison, class prediction, and class discovery and improving the mechanistic understanding of pathological processes and drug action through custom software tool development

Dr. Brachat earned his B.S. in Biochemistry from Ludwig-Maximillians University in Munich, Germany, and graduated summa cum laude with his Ph.D. in Genetics from the University of Basel in Switzerland. In his role with Accenius, Dr. Brachat will research new strategies for oncology-immunotherapy discovery, molecular target discovery, biomarker development, and personalized treatment identification.